These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17766107)

  • 1. Structure-activity relationship study of novel NR2B-selective antagonists with arylamides to avoid reactive metabolites formation.
    Kawai M; Sakurada I; Morita A; Iwamuro Y; Ando K; Omura H; Sakakibara S; Masuda T; Koike H; Honma T; Hattori K; Takashima T; Mizuno K; Mizutani M; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5537-42. PubMed ID: 17766107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzimidazole-2-carboxamides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Gere A; Nagy J; Fodor L; Galgóczy K; Fetter J; Bertha F; Agai B; Horváth C; Farkas S; Domány G
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4638-40. PubMed ID: 16782335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
    Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxamides as novel NR2B selective NMDA receptor antagonists.
    Barta-Szalai G; Borza I; Bozó E; Kiss C; Agai B; Proszenyák A; Keseru GM; Gere A; Kolok S; Galgóczy K; Horváth C; Farkas S; Domány G
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3953-6. PubMed ID: 15225705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach.
    Mony L; Triballeau N; Paoletti P; Acher FC; Bertrand HO
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5552-8. PubMed ID: 20692832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel and orally active NR2B-selective N-methyl-D-aspartate (NMDA) antagonists, pyridinol derivatives with reduced HERG binding affinity.
    Kawai M; Nakamura H; Sakurada I; Shimokawa H; Tanaka H; Matsumizu M; Ando K; Hattori K; Ohta A; Nukui S; Omura A; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5533-6. PubMed ID: 17768047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.
    McIntyre CJ; McCauley JA; Bednar B; Bednar RA; Butcher JW; Claremon DA; Cunningham ME; Freidinger RM; Gaul SL; Homnick CF; Koblan KS; Mosser SD; Romano JJ; Liverton NJ
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5132-5. PubMed ID: 19648007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of (-)-6-[2-[4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl]-1-hydroxyethyl]-3,4-dihydro-2(1H)-quinolinone--a potent NR2B-selective N-methyl D-aspartate (NMDA) antagonist for the treatment of pain.
    Kawai M; Ando K; Matsumoto Y; Sakurada I; Hirota M; Nakamura H; Ohta A; Sudo M; Hattori K; Takashima T; Hizue M; Watanabe S; Fujita I; Mizutani M; Kawamura M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5558-62. PubMed ID: 17766106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.
    Mosley CA; Myers SJ; Murray EE; Santangelo R; Tahirovic YA; Kurtkaya N; Mullasseril P; Yuan H; Lyuboslavsky P; Le P; Wilson LJ; Yepes M; Dingledine R; Traynelis SF; Liotta DC
    Bioorg Med Chem; 2009 Sep; 17(17):6463-80. PubMed ID: 19648014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of 4-methylbenzyl 4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate, an orally bioavailable, brain penetrant NR2B selective N-methyl-D-aspartate receptor antagonist.
    Liverton NJ; Bednar RA; Bednar B; Butcher JW; Claiborne CF; Claremon DA; Cunningham M; DiLella AG; Gaul SL; Libby BE; Lyle EA; Lynch JJ; McCauley JA; Mosser SD; Nguyen KT; Stump GL; Sun H; Wang H; Yergey J; Koblan KS
    J Med Chem; 2007 Feb; 50(4):807-19. PubMed ID: 17249648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists.
    Gitto R; De Luca L; Ferro S; Citraro R; De Sarro G; Costa L; Ciranna L; Chimirri A
    Bioorg Med Chem; 2009 Feb; 17(4):1640-7. PubMed ID: 19157884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly.
    Gu B; Nakamichi N; Zhang WS; Nakamura Y; Kambe Y; Fukumori R; Takuma K; Yamada K; Takarada T; Taniura H; Yoneda Y
    J Neurosci Res; 2009 Jul; 87(9):2145-56. PubMed ID: 19224577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptor NR2B subunit over-expression increases cerebellar granule cell migratory activity.
    Tárnok K; Czöndör K; Jelitai M; Czirók A; Schlett K
    J Neurochem; 2008 Feb; 104(3):818-29. PubMed ID: 18005003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
    Schotanus SM; Chergui K
    Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NR2B subunit in NMDA receptors is functionally important during cerebellar granule cell migration.
    Mancini JD; Atchison WD
    Neurosci Lett; 2007 Dec; 429(2-3):87-90. PubMed ID: 18006154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrrolinones as N-methyl-D-aspartate receptor antagonists.
    Poschenrieder H; Stachel HD; Höfner G; Mayer P
    Eur J Med Chem; 2005 Apr; 40(4):391-400. PubMed ID: 15804538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indole-2-carboxamidines as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Ignácz-Szendrei G; Greiner I; Tárkányi G; Galgóczy K; Horváth C; Farkas S; Domány G
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5439-41. PubMed ID: 16213709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New benzoyl urea derivatives as novel NR2B selective NMDA receptor antagonists.
    Borza I; Greiner I; Kolok S; Galgóczy K; Ignácz-Szendrei G; Horváth C; Farkas S; Gáti T; Háda V; Domány G
    Pharmazie; 2006 Sep; 61(9):799-800. PubMed ID: 17020160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrazole based amides as growth hormone secretagogues.
    Li JJ; Wang H; Li J; Qu F; Swartz SG; Hernández AS; Biller SA; Robl JA; Tino JA; Slusarchyk D; Seethala R; Sleph P; Yan M; Grover G; Flynn N; Murphy BJ; Gordon D
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2536-9. PubMed ID: 18378446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.